Clinical ResearchPulmonary EmbolismClinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department: Initial Report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry)
Key Words
Abbreviations and Acronyms
Cited by (0)
Funding was provided by GlaxoSmithKline. Dr. Pollack has served as a consultant and a speaker for Sanofi-Aventis and has received research funding from Sanofi-Aventis and GlaxoSmithKline. Dr. Goldhaber is a consultant for Sanofi-Aventis, Eisai, Bristol-Myers Squibb, Boehringer Ingelheim, and Medscape. Dr. Fanikos has served as a consultant to Sanofi-Aventis and GlaxoSmithKline. Dr. O'Neil is on the Speakers Bureau for GlaxoSmithKline, Sanofi-Aventis, and Bristol-Myers Squibb; and is on the advisory board for Heartscape Technologies. Dr. Hiestand has received research funding from Medtronic Inc., Biosite Inc., Inovise Medical Inc., Heartscape International, Nanosphere Inc., Mitsubishi Medience, and The Medicines Company; and has a medical writing consulting relationship with newMentor Inc. Dr. Pendleton is on the Speakers Bureau for Sanofi-Aventis; and has received research support from Pfizer, Bristol-Myers Squibb, and Boehringer Ingelheim. Dr. Miller has received research support from Siemens, Breathquant Medical LLC, Biosite, Schering-Plough, Johnson and Johnson/Scios Inc., and PDL Biopharma and served as a speaker for Genentech and at CME events sponsored by Sanofi-Aventis and Schering-Plough and as a consultant to Breathquant Medical LLC, the Medicines Company, and Molecular Insight. Dr. Kline has received funding from the National Institutes of Health and has been a clinical investigator on a clinical trial sponsored by Octapharma (octaplex) and a clinical trial sponsored by Pfizer (apixaban) and a primary investigator on an investigator-initiated clinical trial funded by Genentech; he has stock ownership in CP Diagnostics, a privately held LLC in North Carolina. All other authors have reported that they have no relationships to disclose.